MedPath

VANISH: The evolution of pulmonary lesions on high resolution computed tomography scans in immunocompromised children with a suspected invasive fungal disease.

Recruiting
Conditions
Patiënten die een HSCT ontvangen
Invasive pulmonary fungal infection AND fungal lung infection
10017528
10027655
Registration Number
NL-OMON56261
Lead Sponsor
Prinses Máxima Centrum voor Kinderoncologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
32
Inclusion Criteria

Children from 0 up to and including 18 years with a hemato-oncological
maligancy or post-HSCT and diagnosed with a possible, probable or proven
invasive aspergillosis

Exclusion Criteria

Refusal to give informed consent or not able to give informed consent and
patient is unable to undergo a HRCT scan without anaesthesia.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath